Sunshine Heart Inc (SSH) 0.96 $SSH
Sunshine Heart to Announce Second Quarter 2016 Results on August 9, 2016
GlobeNewswire - Fri Jul 29, 12:30PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its second quarter 2016 results will be released on Tuesday, August 9, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.96 (+0.06)
Sunshine Heart Announces Clinical Update and Product Development Strategy
GlobeNewswire - Mon Jul 11, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update to its clinical strategy that could benefit an underserved population of patients with Class III heart failure and other related conditions.
SSH: 0.96 (+0.06)
Sunshine Heart Announces OPTIONS HF Clinical Experience
GlobeNewswire - Tue May 24, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its C-Pulse Heart Assist System was featured in a clinical presentationat the Heart Failure Association of the European Society of Cardiology Meeting, taking place from May 21 to May 24 in Florence, Italy.
SSH: 0.96 (+0.06)
Sunshine Heart to Release First Quarter 2016 Results on May 3, 2016
GlobeNewswire - Wed Apr 27, 3:15PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its first quarter 2016 results will be released on Tuesday, May 3, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.96 (+0.06)
Sunshine Heart to Present at the Cowen and Company 36th Annual Health Care Conference on March 8, 2016
GlobeNewswire - Mon Mar 07, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer and President, John Erb, is scheduled to present at the Cowen and Company 36th Annual Health Care Conference in Boston, MA on March 8 at 10:40 AM ET.
SSH: 0.96 (+0.06)
Sunshine Heart awards stock options to Eric Lovett, PhD under NASDAQ Listing Rule 5635(c)(4)
M2 - Wed Jan 20, 7:22AM CST
Medical device company Sunshine Heart (NasdaqCM:SSH) said on Tuesday that board of directors' compensation committee has approved an equity award to Eric Lovett, PhD under its New-Hire Equity Incentive Plan and NASDAQ Listing Rule 5635(c)(4).
SSH: 0.96 (+0.06)
Sunshine Heart Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire - Tue Jan 19, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on January 14, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved an equity award to Eric Lovett, Ph.D. under Sunshine Heart's New-Hire Equity Incentive Plan. This grant was made as a material inducement to Dr. Lovett's entering into employment with the Company. The equity award was approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.
SSH: 0.96 (+0.06)
Sunshine Heart Appoints Eric Lovett as Vice President, Clinical Affairs
GlobeNewswire - Tue Jan 05, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced the appointment of Eric Lovett Ph.D., to the position of Vice President, Clinical Affairs. In this capacity, Dr. Lovett will manage the Company's U.S. pivotal study (COUNTER HF(TM)) for its flagship C-Pulse(R) Heart Assist System, a medical device designed to treat patients with moderate to severe heart failure.
SSH: 0.96 (+0.06)
Sunshine Heart Amends Its Debt Agreement with Silicon Valley Bank
GlobeNewswire - Wed Dec 09, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH) announced today it has amended its debt agreement with Silicon Valley Bank to modify the requirement that the Company raise $20.0 million by March 31, 2016.
SSH: 0.96 (+0.06), SIVB: 97.80 (-0.20)
Sunshine Heart Announces Departure of Its Chief Executive Officer David A. Rosa
GlobeNewswire - Mon Nov 30, 3:15PM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer, David A. Rosa is leaving the Company, effective November 30, 2015. John L. Erb, Chairman of the Board of Directors of Sunshine Heart, has been named Interim Chief Executive Officer and President and will continue to serve as Chairman of the Board.
SSH: 0.96 (+0.06)
Sunshine Heart to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015
GlobeNewswire - Wed Nov 25, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Financial Officer, Claudia Drayton, is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference in New York, NY on December 2 at 12:00 PM ET.
SSH: 0.96 (+0.06)
Sunshine Heart Announces Third Quarter 2015 Results and Provides Corporate Update
GlobeNewswire - Tue Nov 03, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the third quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on its ongoing clinical studies.
SSH: 0.96 (+0.06)
Sunshine Heart to Release Third Quarter 2015 Results on November 3, 2015
GlobeNewswire - Tue Oct 27, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its third quarter results will be released on Tuesday, November 3, 2015, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.96 (+0.06)
Sunshine Heart announces inducement stock options to two new hires under NASDAQ Listing Rule 5635(c)(4)
M2 - Fri Oct 09, 6:21AM CDT
Medical device company Sunshine Heart (NasdaqCM:SSH) stated on Thursday that board of directors' compensation committee have approved two equity awards under its new-hire equity incentive plan to two new individuals in accordance with NASDAQ Listing Rule 5635(c)(4).
SSH: 0.96 (+0.06)
Sunshine Heart to Present Hemodynamic Data Supporting Mechanism of Action of the C-Pulse System at 2015 Transcatheter Cardiovascular Therapeutics Conference
GlobeNewswire - Thu Oct 08, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its flagship C-Pulse(R) Heart Assist System will be featured in a clinical presentation at the 27 annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The TCT symposium will take place October 11 -15 in San Francisco, CA at the Moscone Center.
SSH: 0.96 (+0.06)
Sunshine Heart Initiates Animal Study on Applicability of C-Pulse Technology in the Treatment of Pulmonary Arterial Hypertension
GlobeNewswire - Wed Sep 09, 4:30AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today the commencement of a collaborative effort with Dr. Mark Slaughter and the University of Louisville to study the impact of the C-Pulse technology on the pulmonary circulation and right heart, specifically in the field of pulmonary hypertension and heart failure.
SSH: 0.96 (+0.06)
Sunshine Heart to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015
GlobeNewswire - Thu Aug 06, 4:29AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Executive Officer, Dave Rosa, is scheduled to present at the 35th Annual Canaccord Genuity Growth Conference in Boston, MA on August 13th at 8:00 AM ET.
SSH: 0.96 (+0.06)
Sunshine Heart Announces Second Quarter 2015 Results and Provides Corporate Update
GlobeNewswire - Tue Aug 04, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the second quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on its ongoing clinical studies.
SSH: 0.96 (+0.06)
Sunshine Heart to Announce Second Quarter 2016 Results on August 9, 2016
GlobeNewswire - Fri Jul 29, 12:30PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its second quarter 2016 results will be released on Tuesday, August 9, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.96 (+0.06)
Sunshine Heart Announces Clinical Update and Product Development Strategy
GlobeNewswire - Mon Jul 11, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update to its clinical strategy that could benefit an underserved population of patients with Class III heart failure and other related conditions.
SSH: 0.96 (+0.06)
Sunshine Heart Announces OPTIONS HF Clinical Experience
GlobeNewswire - Tue May 24, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its C-Pulse Heart Assist System was featured in a clinical presentationat the Heart Failure Association of the European Society of Cardiology Meeting, taking place from May 21 to May 24 in Florence, Italy.
SSH: 0.96 (+0.06)
Sunshine Heart to Release First Quarter 2016 Results on May 3, 2016
GlobeNewswire - Wed Apr 27, 3:15PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its first quarter 2016 results will be released on Tuesday, May 3, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.96 (+0.06)
Sunshine Heart to Present at the Cowen and Company 36th Annual Health Care Conference on March 8, 2016
GlobeNewswire - Mon Mar 07, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer and President, John Erb, is scheduled to present at the Cowen and Company 36th Annual Health Care Conference in Boston, MA on March 8 at 10:40 AM ET.
SSH: 0.96 (+0.06)
Sunshine Heart awards stock options to Eric Lovett, PhD under NASDAQ Listing Rule 5635(c)(4)
M2 - Wed Jan 20, 7:22AM CST
Medical device company Sunshine Heart (NasdaqCM:SSH) said on Tuesday that board of directors' compensation committee has approved an equity award to Eric Lovett, PhD under its New-Hire Equity Incentive Plan and NASDAQ Listing Rule 5635(c)(4).
SSH: 0.96 (+0.06)
Sunshine Heart Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire - Tue Jan 19, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on January 14, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved an equity award to Eric Lovett, Ph.D. under Sunshine Heart's New-Hire Equity Incentive Plan. This grant was made as a material inducement to Dr. Lovett's entering into employment with the Company. The equity award was approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.
SSH: 0.96 (+0.06)
Sunshine Heart Appoints Eric Lovett as Vice President, Clinical Affairs
GlobeNewswire - Tue Jan 05, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced the appointment of Eric Lovett Ph.D., to the position of Vice President, Clinical Affairs. In this capacity, Dr. Lovett will manage the Company's U.S. pivotal study (COUNTER HF(TM)) for its flagship C-Pulse(R) Heart Assist System, a medical device designed to treat patients with moderate to severe heart failure.
SSH: 0.96 (+0.06)
Sunshine Heart Amends Its Debt Agreement with Silicon Valley Bank
GlobeNewswire - Wed Dec 09, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH) announced today it has amended its debt agreement with Silicon Valley Bank to modify the requirement that the Company raise $20.0 million by March 31, 2016.
SSH: 0.96 (+0.06), SIVB: 97.80 (-0.20)
Sunshine Heart Announces Departure of Its Chief Executive Officer David A. Rosa
GlobeNewswire - Mon Nov 30, 3:15PM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer, David A. Rosa is leaving the Company, effective November 30, 2015. John L. Erb, Chairman of the Board of Directors of Sunshine Heart, has been named Interim Chief Executive Officer and President and will continue to serve as Chairman of the Board.
SSH: 0.96 (+0.06)
Sunshine Heart to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015
GlobeNewswire - Wed Nov 25, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Financial Officer, Claudia Drayton, is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference in New York, NY on December 2 at 12:00 PM ET.
SSH: 0.96 (+0.06)
Sunshine Heart Announces Third Quarter 2015 Results and Provides Corporate Update
GlobeNewswire - Tue Nov 03, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the third quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on its ongoing clinical studies.
SSH: 0.96 (+0.06)
Sunshine Heart to Release Third Quarter 2015 Results on November 3, 2015
GlobeNewswire - Tue Oct 27, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its third quarter results will be released on Tuesday, November 3, 2015, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.96 (+0.06)
Sunshine Heart announces inducement stock options to two new hires under NASDAQ Listing Rule 5635(c)(4)
M2 - Fri Oct 09, 6:21AM CDT
Medical device company Sunshine Heart (NasdaqCM:SSH) stated on Thursday that board of directors' compensation committee have approved two equity awards under its new-hire equity incentive plan to two new individuals in accordance with NASDAQ Listing Rule 5635(c)(4).
SSH: 0.96 (+0.06)
Sunshine Heart to Present Hemodynamic Data Supporting Mechanism of Action of the C-Pulse System at 2015 Transcatheter Cardiovascular Therapeutics Conference
GlobeNewswire - Thu Oct 08, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its flagship C-Pulse(R) Heart Assist System will be featured in a clinical presentation at the 27 annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The TCT symposium will take place October 11 -15 in San Francisco, CA at the Moscone Center.
SSH: 0.96 (+0.06)
Sunshine Heart Initiates Animal Study on Applicability of C-Pulse Technology in the Treatment of Pulmonary Arterial Hypertension
GlobeNewswire - Wed Sep 09, 4:30AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today the commencement of a collaborative effort with Dr. Mark Slaughter and the University of Louisville to study the impact of the C-Pulse technology on the pulmonary circulation and right heart, specifically in the field of pulmonary hypertension and heart failure.
SSH: 0.96 (+0.06)
Sunshine Heart to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015
GlobeNewswire - Thu Aug 06, 4:29AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Executive Officer, Dave Rosa, is scheduled to present at the 35th Annual Canaccord Genuity Growth Conference in Boston, MA on August 13th at 8:00 AM ET.
SSH: 0.96 (+0.06)
Sunshine Heart Announces Second Quarter 2015 Results and Provides Corporate Update
GlobeNewswire - Tue Aug 04, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the second quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on its ongoing clinical studies.
SSH: 0.96 (+0.06)
